A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone. (Q46871639)
Jump to navigation
Jump to search
scientific article published in November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone. |
scientific article published in November 2007 |
Statements
A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone (English)
Benedicto Crespo-Facorro
Rocio Perez-Iglesias
Jose Antonio Amado
Maria Teresa Garcia-Unzueta
Maria Luz Ramirez-Bonilla
Cesar Gonzalez-Blanch
Obdulia Martinez-Garcia
Jose Luis Vazquez-Barquero
1 November 2007